BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1399930)

  • 21. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
    Philpott-Howard J; Burroughs A; Fisher N; Hastings M; Kibbler C; Mutimer D; Patch D; Rolando N; Wade J; Wendon J; O'Grady J
    J Antimicrob Chemother; 2003 Dec; 52(6):993-1000. PubMed ID: 14585863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoeconomics of aztreonam-clindamycin versus gentamicin-clindamycin in the treatment of penetrating abdominal injury.
    Fabian TC; Boucher BA; Croce MC
    Pharmacotherapy; 1996; 16(5):951-7. PubMed ID: 8888092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.
    Fagon J; Patrick H; Haas DW; Torres A; Gibert C; Cheadle WG; Falcone RE; Anholm JD; Paganin F; Fabian TC; Lilienthal F
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):753-62. PubMed ID: 10712318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
    Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP
    Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study of latamoxef disodium and gentamicin versus piperacillin and gentamicin in febrile granulocytopenic patients.
    O'Brien AJ; Fenelon LE; O'Dwyer R; McCann SR; Daly PA
    Br J Clin Pract; 1988 Feb; 42(2):56-60. PubMed ID: 3179173
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.
    Leyland MJ; Bayston KF; Cohen J; Warren R; Newland AC; Bint AJ; Cefai C; White DG; Murray SA; Bareford D
    J Antimicrob Chemother; 1992 Dec; 30(6):843-54. PubMed ID: 1289359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
    Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
    Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
    Rutter WC; Cox JN; Martin CA; Burgess DR; Burgess DS
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial.
    Sacchidanand S; Penn RL; Embil JM; Campos ME; Curcio D; Ellis-Grosse E; Loh E; Rose G
    Int J Infect Dis; 2005 Sep; 9(5):251-61. PubMed ID: 16099700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aztreonam versus gentamicin for short-term prophylaxis in biliary and gastric surgery.
    Rodolico G; Puleo S; Blandino G; Scilletta B; Cavallaro V; Latteri F; Veroux G; Nicoletti G
    Rev Infect Dis; 1991; 13 Suppl 7():S616-20. PubMed ID: 2068469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
    Albertazzi A; Bonadio M; Fusaroli M; Lotti T; Miano L; Salvia G; Sasdelli M; Villa G; Zucchelli P; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan.
    Chuang YC; Chang CM; Aradhya S; Nagari B; Pai V; Dartois N; Jouve S; Cooper A
    J Microbiol Immunol Infect; 2011 Apr; 44(2):116-24. PubMed ID: 21439514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
    Navalkele B; Pogue JM; Karino S; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Koons J; Hussain T; Perry W; Evans R; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Kaye KS
    Clin Infect Dis; 2017 Jan; 64(2):116-123. PubMed ID: 27986669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aztreonam compared with gentamicin for treatment of serious urinary tract infections.
    Sattler FR; Moyer JE; Schramm M; Lombard JS; Appelbaum PC
    Lancet; 1984 Jun; 1(8390):1315-8. PubMed ID: 6145024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participants.
    Wong SL; Sörgel F; Kinzig M; Goldberg MR; Kitt MM; Barriere SL
    J Clin Pharmacol; 2009 Jul; 49(7):816-23. PubMed ID: 19443680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
    Cometta A; Kern WV; De Bock R; Paesmans M; Vandenbergh M; Crokaert F; Engelhard D; Marchetti O; Akan H; Skoutelis A; Korten V; Vandercam M; Gaya H; Padmos A; Klastersky J; Zinner S; Glauser MP; Calandra T; Viscoli C;
    Clin Infect Dis; 2003 Aug; 37(3):382-9. PubMed ID: 12884163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
    Carreno J; Smiraglia T; Hunter C; Tobin E; Lomaestro B
    Int J Antimicrob Agents; 2018 Nov; 52(5):643-650. PubMed ID: 30103003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.
    Breedt J; Teras J; Gardovskis J; Maritz FJ; Vaasna T; Ross DP; Gioud-Paquet M; Dartois N; Ellis-Grosse EJ; Loh E;
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4658-66. PubMed ID: 16251309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.